- Home
- REPL vs DADA Comparison
REPL vs DADA Comparison
Compare REPL & DADA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- DADA
- Stock Information
- Founded
- REPL 2015
- DADA 2014
- Country
- REPL United States
- DADA China
- Employees
- REPL N/A
- DADA N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- DADA Computer Software: Programming Data Processing
- Sector
- REPL Health Care
- DADA Technology
- Exchange
- REPL Nasdaq
- DADA Nasdaq
- Market Cap
- REPL 578.4M
- DADA 488.1M
- IPO Year
- REPL 2018
- DADA 2020
- Fundamental
- Price
- REPL $8.98
- DADA $2.02
- Analyst Decision
- REPL Strong Buy
- DADA Buy
- Analyst Count
- REPL 6
- DADA 2
- Target Price
- REPL $20.00
- DADA $2.95
- AVG Volume (30 Days)
- REPL 1.6M
- DADA 4.1M
- Earning Date
- REPL 05-22-2025
- DADA 06-10-2025
- Dividend Yield
- REPL N/A
- DADA N/A
- EPS Growth
- REPL N/A
- DADA N/A
- EPS
- REPL N/A
- DADA N/A
- Revenue
- REPL N/A
- DADA $1,323,968,707.00
- Revenue This Year
- REPL N/A
- DADA $14.26
- Revenue Next Year
- REPL N/A
- DADA $13.29
- P/E Ratio
- REPL N/A
- DADA N/A
- Revenue Growth
- REPL N/A
- DADA N/A
- 52 Week Low
- REPL $4.93
- DADA $1.04
- 52 Week High
- REPL $17.00
- DADA $2.52
- Technical
- Relative Strength Index (RSI)
- REPL 53.81
- DADA 51.60
- Support Level
- REPL $8.25
- DADA $1.97
- Resistance Level
- REPL $9.53
- DADA $2.10
- Average True Range (ATR)
- REPL 0.88
- DADA 0.06
- MACD
- REPL 0.17
- DADA -0.00
- Stochastic Oscillator
- REPL 71.10
- DADA 21.74
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About DADA Dada Nexus Limited
Dada Nexus provides on-demand retail platform services and fulfillment services to retailers to sell their products, and online advertising and marketing services to its customers such as brand owners or their agents. It also provides last-mile, intracity and intercity delivery services to logistics companies, merchants and individuals on the Dada Now platform. The group fulfills the delivery needs of retailers on JD Now and customers on Dada Now mostly by utilizing registered riders on Dada Now. Dada's average delivery time for on-demand intracity delivery orders was within 30 minutes in 2023, faster than traditional e-commerce where delivery can take days. As of Sept. 16, 2024, JD.com owned 63.2% of Dada Nexus. Dada Nexus competes with Meituan, Ele.me, Douyin, and SF Intra-city.